质子治疗对成人脑肿瘤患者认知功能影响的系统综述
本系统综述遵循PRISMA指南并在PROSPERO注册,纳入8项研究共310例成人原发性脑肿瘤患者(其中247例接受质子治疗),评估质子治疗对多个认知域的影响。结果显示质子治疗与整体认知、记忆、语言、执行功能、注意力、工作记忆及视空间能力的稳定或改善相关,无研究报道进行性认知下降;左侧病灶患者恢复更好,而出现放射性脑损伤或毒性的患者结局更差。
要点
- 质子治疗与成人脑肿瘤患者多数认知域稳定或改善相关,无进行性下降报道。
- 左侧病灶患者认知恢复更好,放射性脑损伤或毒性患者结局更差。
- 证据限于8项研究310例患者,需大规模多中心长期随访验证。
核心结论
- 质子治疗似乎是成人颅内肿瘤的认知保留性治疗方式,多数认知域保持稳定或随时间改善。
- 出现治疗相关毒性的患者可能面临更高的认知损害风险。
研究设计与样本
- 系统综述遵循PRISMA指南,已在PROSPERO注册(ID: CRD42024591714)。
- 纳入8项研究共310例成人(>18岁)原发性脑肿瘤患者,其中247例接受质子治疗。
- 检索PubMed、Embase和Scopus,使用混合方法评价工具评估方法学质量。
主要发现
- 质子治疗与整体认知、记忆、语言、执行功能、注意力、工作记忆及视空间能力的稳定或改善相关。
- 无研究报告进行性认知下降。
- 长期随访中常观察到改善,尤其在没有治疗诱导毒性的患者中。
- 亚组分析显示左侧病灶患者恢复更好,放射性脑损伤或毒性患者结局更差。
关键数值与推荐
- 纳入标准:成人(>18岁)原发性脑肿瘤接受质子治疗并使用标准化神经心理测试评估。
- 排除标准:儿科人群、转移瘤、仅自我报告评估及其他放疗技术。
临床怎么用
- 质子治疗可作为成人原发性脑肿瘤的认知保留性选择,尤其适用于左侧病灶患者。
- 对出现放射性脑损伤或治疗相关毒性的患者应加强认知监测。
局限性
- 纳入研究数量有限(8项),样本量较小(310例)。
- 肿瘤类型异质,包括胶质瘤、脑膜瘤、颅咽管瘤等。
- 需要大规模、多中心、更长随访及认知域特异性评估的试验来确认 findings。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Proton therapy (pt) is increasingly employed in treating of intracranial neoplasms due to its ability to spare surrounding healthy tissue. However, its effects on cognitive function in adult patients remain unclear, despite rising clinical adoption. This review systematically evaluates evidence on neurocognitive outcomes in adults treated with pt for primary intracranial tumors, and assess its impact across multiple cognitive domains. METHODS: This review followed PRISMA guidelines and was registered on PROSPERO (ID: CRD42024591714). Eligible studies included adults ( > 18 years) with primary brain tumors treated with PT and assessed using standardized neuropsychological tests. Pediatric populations, metastases, self-report-only assessments, and other radiotherapy techniques were excluded. Literature was searched across PubMed, Embase, and Scopus. Methodological quality was appraised using the Mixed Methods Appraisal Tool. RESULTS: Eight studies comprising 310 patients (247 receiving PT) were included. Tumor types varied and included gliomas, meningiomas, craniopharyngiomas, and others. Overall, PT was associated with stable or improved outcomes in global cognition, memory, language, executive function, attention, working memory, and visuospatial abilities. No study reported progressive cognitive decline. Improvements were often observed over long-term follow-up, particularly in patients without treatment-induced toxicity. Subgroup analyses revealed better recovery in left-sided lesions and worse outcomes in patients with radiation-induced brain lesions or toxicities. CONCLUSION: PT appears to be a cognitively sparing modality for treating intracranial neoplasms in adults. While most cognitive domains are preserved or improve over time, patients experiencing treatment-related toxicities may be at higher risk of impairment. Future large-scale, multicenter trials with longer follow-ups and domain-specific assessments are warranted to confirm these findings and optimize treatment protocols.
引用
- Scagliotti E, Capetti B, Conti L, et al. Effects of proton therapy on cognition in adults with brain tumors: a systematic review. J Neurooncol. 2025. PMID: 41385035. doi:10.1007/s11060-025-05371-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。